dc.contributor.author | Mirza-Aghazadeh-Attari, M | |
dc.contributor.author | Darband, SG | |
dc.contributor.author | Kaviani, M | |
dc.contributor.author | Mihanfar, A | |
dc.contributor.author | Aghazadeh Attari, J | |
dc.contributor.author | Yousefi, B | |
dc.contributor.author | Majidinia, M | |
dc.date.accessioned | 2018-08-26T08:51:54Z | |
dc.date.available | 2018-08-26T08:51:54Z | |
dc.date.issued | 2018 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/53563 | |
dc.description.abstract | DNA damage response, a key factor involved in maintaining genome integrity and stability, consists of several kinase-dependent signaling pathways, which sense and transduce DNA damage signal. The severity of damage appears to determine DNA damage responses, which can include cell cycle arrest, damage repair and apoptosis. A number of recent studies have demonstrated that defection in signaling through this network is thought to be an underlying mechanism behind the development and progression of various types of human malignancies, including colorectal cancer. In this review, colorectal cancer and its molecular pathology as well as DNA damage response is briefly introduced. Finally, the involvement of key components of this network in the initiation/progression, prognosis, response to treatment and development of drug resistance is comprehensively discussed. é 2018 | |
dc.language.iso | English | |
dc.relation.ispartof | DNA Repair | |
dc.subject | ATR protein | |
dc.subject | BRCA1 protein | |
dc.subject | checkpoint kinase 1 | |
dc.subject | cyclic AMP dependent protein kinase | |
dc.subject | cyclin dependent kinase inhibitor 1A | |
dc.subject | DNA topoisomerase (ATP hydrolysing) | |
dc.subject | double strand break repair protein MRE11 | |
dc.subject | double stranded DNA | |
dc.subject | histone H2AX | |
dc.subject | nucleic acid binding protein | |
dc.subject | phosphatidylinositol 3 kinase | |
dc.subject | phosphotransferase wee1 | |
dc.subject | protein Bax | |
dc.subject | protein Noxa | |
dc.subject | protein p16 | |
dc.subject | protein p53 | |
dc.subject | protein rad17 | |
dc.subject | PUMA protein | |
dc.subject | Rad50 protein | |
dc.subject | replication factor A | |
dc.subject | tumor suppressor p53 binding protein 1 | |
dc.subject | unclassified drug | |
dc.subject | apoptosis | |
dc.subject | carcinogenesis | |
dc.subject | cell cycle arrest | |
dc.subject | cell cycle checkpoint | |
dc.subject | colorectal cancer | |
dc.subject | disease severity | |
dc.subject | DNA damage response | |
dc.subject | DNA end joining repair | |
dc.subject | DNA repair | |
dc.subject | double stranded DNA break | |
dc.subject | excision repair | |
dc.subject | homologous recombination | |
dc.subject | human | |
dc.subject | priority journal | |
dc.subject | protein phosphorylation | |
dc.subject | Review | |
dc.title | DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications | |
dc.type | Article | |
dc.citation.volume | 69 | |
dc.citation.spage | 34 | |
dc.citation.epage | 52 | |
dc.citation.index | Scopus | |
dc.identifier.DOI | https://doi.org/10.1016/j.dnarep.2018.07.005 | |